Statement: patients with hormone receptor positive advanced lung cancer, who have undergone chemotherapy for this specific cancer, can participate in the primary clinical trial.
Primary_evidence: Inclusion Criteria:   Confirmed hormone receptor positive advanced breast cancer, postmenopausal women Exclusion Criteria:   Previous treatment for advanced breast cancer (previous treatment for early breast cancer is allowed).